In those patients in whom TAT‐based vaccination was performed, increased memory CD4 and CD8 cells were observed alongside increased proviral DNA decay in animal models which may abrogate initial infection making this an attractive target for future vaccine design.128. This evidence concerns the gene CD8A and infection.